12:49 PM EST - ProMetic Life Sciences, Inc. : announced the it and Allist Pharmaceuticals Inc. have come to terms to develop and commercialize two ProMetic's drug candidates in China. Per the agreement, ProMetic will receive $59 million in milestone payments and royalties on Chinese sales. Shares of PLI are up 20.83% to $0.145. ProMetic Life Sciences, Inc.
shares T.PLI are trading up $.03 at $0.15.
